|
||||||||||||
 |
||||||||||||
 |
|
|||||||||||
|
|
|
Research: Gilligan Lab Publications
Gilligan, D.M. and B.H. Satir. 1982. Protein phosphorylation/ dephosphorylation and stimulus-secretion coupling in wild type and mutant Paramecium. J. Biol. Chem. 257:13903-13906. Garofalo, R.S., D.M. Gilligan and B.H. Satir. 1983. Calmodulin antagonists inhibit secretion in Paramecium. J. Cell Biol. 96:1072-1081. Gilligan, D.M. and B.H. Satir. 1983. Stimulation and inhibition of secretion in Paramecium: role of divalent cations. J. Cell Biol. 97:224-234. Murtaugh, T.J., D.M. Gilligan and B.H. Satir. 1987. Purification of and production of an antibody against a 63,000 Mr stimulus-sensitive phosphoprotein in Paramecium. J. Biol. Chem. 262:15734-15739. Blasband, A., D.M. Gilligan, S. Wong, L. Winchell and D. Lee. 1990. Expression of TGF-alpha integral membrane precursor induces transformation of NRK cells. Oncogene 5:1213-1221. Joshi, R., D.M. Gilligan, E. Otto, T. McLaughlin, and V. Bennett. 1991. Primary structure and domain organization of human alpha and beta adducin. J. Cell Biol. 115:665-675. Gilligan, D.M., J. Lieman, and V. Bennett. 1995. Assignment of the human beta adducin gene (ADD2) to 2p13-14 by in situ hybridization. Genomics 28:610-612. Gilligan, D.M., L. Lozovatsky, and A. Silberfein. 1997. Organization of the human beta adducin gene (ADD2). Genomics 43:141-148. Bejaoui, K., J. Liu, D. McKenna-Yasek, D. LePaslier, K. Bossie, D.M. Gilligan, and R.H. Brown. 1998. Genetic fine mapping of the Miyoshi myopathy locus and exclusion of eight candidate genes, Neurogenetics 1:189-196. Sinard, J.H., G.W. Stewart, P.R. Stabach, A.C. Argent, D.M. Gilligan, and J.S. Morrow. 1998. Utilization of an 86 bp exon generates a novel adducin isoform (b4) lacking the MARCKS homology domain. Biochem.Biophys.Acta 1396:57-66. Snyder, E.L., P. Perrotta, H. Rinder, L. Baril. J. Nichol, and D.M. Gilligan. 1999. Effect of recombinant human megakaryocyte growth and development factor coupled with polyethylene glycol on the platelet storage lesion. Transfusion 39:258-264. Innes, D.S., J.H. Sinard, D.M. Gilligan, L.M. Snyder, P.G. Gallagher and J.S. Morrow. 1999. Exclusion of the stomatin, a-adducin and b-adducin loci in a large kindred with dehydrated hereditary stomatocytosis. Am. J. Hematology 60:72-74. Gilligan, D.M., L.Lozovatsky, B. Gwynn, C. Brugnara, M. Narla, and L.L. Peters. Targeted disruption of the beta adducin gene causes spherocytosis in mice. Proc. Natl. Acad. Sci. (USA) 1999. 96:10717-10722. Suriyapperuma, S., L. Lozovatsky, S.L. Ciciotte, L.L. Peters and D.M. Gilligan. The murine adducin gene family: alternative splicing and chromosomal localization. Mammalian Genome 2000. 11:16-23. Gilligan, D.M., R. Sarid, and J. Weese. Adducin in platelets: activation-induced phosphorylation by PKC and proteolysis by calpain. Blood 2002 99:2418-2426. Gruenbaum, L.M., D.M. Gilligan, M.R. Picciotto, S. Marinesco, and T.J. Carew. Identification and characterization of Aplysia adducin, an aplysia cytoskeletal protein homologous to mammalian adducins: increased phosphorylation at a protein kinase C consensus site during long-term synaptic facilitation. J. Neurosci. 2003 23:2675-2685. Nester, T.A., D.M. Rumsey, C.C. Howell, D.M. Gilligan, J.G. Drachman, R.V. Maier, D.M. Kyles, D.C. Matthews, T.W. Pendergrass. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin. Transfusion. 2004; 44:1720-3. Rabenstein, R.L., N.A. Addy, B.J. Caldarone, Y. Asaka, L.M. Gruenbaum, L.L. Peters, D.M. Gilligan, R.M. Fitzsimonds, M.R. Picciotto. Impaired Synaptic Plasticity and Leanring in Mice Lacking β-Adducin, an Actin-Regulationg Protein. J Neurosci. 2005;25:2138-45. Yenerel, M.N., I.B. Sundell, J. Weese, M. Bulger, D.M. Gilligan. Expression of Adducin Genes During Erythropoiesis: A Novel Erythroid Promoter for ADD2. Exp. Hematology, 2005, 33:758-766.Book Chapters:
|
|
||||||||
|
 |
|||||||||||
 |
||||||||||||
|
||||||||||||
